Lv11
100 积分 2026-03-08 加入
A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder
1个月前
已完结
Spotlight on the Pharmacoeconomics of Escitalopram in Depression1
1个月前
已完结
Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine Extended-Release as First-Line Treatment in Major Depressive Disorder
1个月前
已完结
Cost-effectiveness analysis of utidelone plus capecitabine for metastatic breast cancer in China
2个月前
已完结
Cost-effectiveness Analysis of Trastuzumab Emtansine as Second-line Therapy for HER2-Positive Breast Cancer in China
2个月前
已完结
皖公网安备34019202002308
